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Background: Most smokers who quit typically do so unassisted although pharmaceutical products are increasingly
used by those who want a quitting aid. Previous Scandinavian surveys indicated that many smokers stopped
smoking by switching from cigarettes to smokeless tobacco in the form of snus. However, usage of various
cessation aids may have changed in Sweden during recent years due to factors such as the wider availability of
pharmaceutical nicotine, the public debate about the health effects of different tobacco products, excise tax
increases on snus relative to cigarettes, and the widespread public misconception that nicotine is the main cause of
the adverse health effects associated with tobacco use.
Methods: A population-based, cross-sectional survey was done during November 2008 and September 2009
including 2,599 males and 3,409 females aged between 18 and 89 years. The sampling technique was random digit
dialing. Data on tobacco habits and quit attempts were collected through structured telephone interviews.
Results: The proportion of ever smokers was similar among males (47%) compared to females (44%). About two
thirds of them reported having stopped smoking at the time of the survey. Among the former smokers, the
proportion who reported unassisted quitting was slightly lower among males (68%) compared to females (78%).
Among ever smokers who reported having made assisted quit attempts, snus was the most frequently reported
cessation aid among males (22%), whereas females more frequently reported counseling (8%), or pharmaceutical
nicotine (gum 8%, patch 4%). Of those who reported using snus at their latest quit attempt, 81% of males and 72%
of females were successful quitters compared to about 50-60% for pharmaceutical nicotine and counseling.
Conclusions: This survey confirms and extends previous reports in showing that, although most smokers who have
quit did so unassisted, snus continues to be the most frequently reported cessation aid among male smokers,
whereas usage of pharmaceutical nicotine was more prevalent among females. Use of snus at the latest quit
attempt appeared to be associated with a higher success rate among both males and females than other reported
methods, although statistically significant differences were mainly observed among males.
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Most smokers who quit typically do so unassisted [1,2].
In many countries there is also a widespread use of vari-
ous cessation aids. The efficacy of several pharmaceutical
products has been documented to increase quit rates in
controlled clinical trials [3,4], but their effect on a popu-
lation level appears more modest in relation to the total
number of excess deaths due to smoking each year [5].
In Scandinavia, population surveys have indicated thatCorrespondence: lars-erik.rutqvist@swedishmatch.com
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reproduction in any medium, provided the orsmokeless tobacco in the form of Swedish snus has been
used by many smokers to quit cigarettes [6,7]. But the
role of snus for smoking cessation remains controversial
[8,9]. Critics have suggested that the observational char-
acter of the data on switch from cigarettes to snus pre-
cludes causal inferences. Also, until recently, there were
no controlled clinical trials on the efficacy of snus for
smoking cessation purposes [10,11].
Use of cessation aids may have changed in Sweden in
recent years. Pharmaceutical nicotine products have be-
come more widely available. They are sold without a
prescription since 1990 and are available in convenienceThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Rutqvist Harm Reduction Journal 2012, 9:38 Page 2 of 6
http://www.harmreductionjournal.com/content/9/1/38stores and supermarkets since 2008. The prescription
drug varenicline was registered in 2006. In the public de-
bate, some public health authorities have discouraged
smokers from using snus as a cessation aid [8]. The ex-
cise tax on snus was increased substantially during the
past decade. A widespread public misconception has also
been documented that nicotine is the cause of much of
the adverse health effects associated with smoking [12].
This may deter cigarette smokers who want to quit from
using pharmaceutical nicotine products as well as snus.
In the light of these circumstances, the current
population-based survey was done to assess cessation
strategies among Swedish smokers at their latest quit
attempt.
Methods
Survey scheme and subject selection
The survey was based on a cross-sectional, population-
based sample of subjects living in Sweden aged 18+
years. The total Swedish population in that age range is
about 7.4 million. The study was designed to be geo-
graphically representative, so the number contacted in
each administrative region reflected the region’s popula-
tion size relative to the total population of Sweden
according to Statistics Sweden. Subject selection was
done in two consecutive steps. First, a population of
households was defined from which selection was done
by means of random digit dialing (RDD). For this pur-
pose, the largest provider of telephone directories in
Sweden (Eniro AB) supplied a database including infor-
mation about private telephone extensions in Sweden.
The database includes information on about 3.6 million
households and is updated every three months. It does
not include households with only mobile phones but
does include lines registered in the Swedish Telephone
Preference Service (NIX-Telefon) which allows consu-
mers to register that they do not want to receive market-
ing, sales or charity collection calls by telephone.
Secondly, one subject was selected from each household
based on the household member having the most recent
birthday. Each selected subject, if unavailable, was con-
tacted by up to seven telephone calls, before being
replaced by a new subject from another household. If
unable or unwilling to participate, the selected subject
was not substituted by another member of the same
household.
In total, 15,178 telephone numbers were contacted
which resulted in identification of 8,534 potential sub-
jects. Of these 6,008 (70.4%) provided informed consent
to participate in a telephone-based, structured interview
about their tobacco habits. Of the 6,644 telephone num-
bers which did not result in identification of a potential
subject 35% resulted in no contact, 2% were non-
existent or were connected to a fax-machine, 6%concerned ineligible subjects, and 23% refused all form
of contact pertinent to the survey. The 6,008 eligible
subjects included in the study received no rewards or
compensations for their participation. The interviews
were done in November 2008 (n=1,000), and in Septem-
ber 2009 (n=5,008). Subject selection and telephone
interviews were done by one of Sweden’s largest com-
panies for opinion and market research (Demoskop AB)
and was sponsored by Swedish Match AB.Telephone interview
The interview was structured through use of a question-
naire including 12 questions about present and former
tobacco habits (see Appendix). For instance, ever smo-
kers were asked about quit attempts, and use of quitting
aids. All interviews were done by telephone. The inter-
viewers used a computer aided telephone interviewing
system for documentation. In total, 57 qualified inter-
viewers were involved. Typically, each interview lasted c.
2 minutes. They were done on weekdays between 5 and
9 pm, and on weekends between 11 am and 3 pm. All
interviewers worked under professional secrecy and
according to the ethical guidelines published by the
European Society for Opinion and Marketing Research
(ESOMAR). In order to avoid the risk of bias in the
data collection, the sponsor of the research was kept
anonymous for both interviewers and subjects through-
out the project. Also, to ensure consistency and quality
of the interviews listening in and recording of inter-
views was done according to standard routines at
Demoskop AB.Statistical methods
The sample size was determined on the basis of consid-
erations related to the statistical uncertainty of estimates
of the size of population subsets. Preliminary data indi-
cated that a total sample size of c. 6,000 would generate
c. 2,600 subjects with a history of smoking and quit
attempts. Within a group of that size, an estimated pro-
portion of 50% would be associated with a 95% confi-
dence interval of +/−1.9%. For the whole survey, a
proportion of 10% and 20% would be associated with a
95% confidence interval of +/−0.8%, and +/−1.0%, re-
spectively. The statistical analyses were done by means
of the statistical packages Base SASW and SAS/StatW
(version 9.2, SAS, North Carolina, USA). Distributional
comparisons were done using non-parametric (chi-
squared) statistical tests. Two-sided p-values <0.05 were
considered statistically significant. Reported proportions
were weighted on the base of age and gender, where
appropriate, so that the results would correctly represent
the Swedish population according to Statistics Sweden.
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Prevalence of current tobacco use
The survey included 2,599 males and 3,409 females aged
18 through 89 years. The overall prevalence of current
tobacco use (regular or occasional use) was 31.3%
among males and 17.5% among females (Table 1). The
prevalence of current smoking was about 15% among
both males and females. Snus was used much more fre-
quently by males (21.1%) than by females (3.8%).
Smoking history
The overall proportion of ever smokers was similar
among males (47%) compared to females (44%) (Table 2).
Ever smoking was generally more frequent among males
aged above 54 years, and among women aged 45–64
years. Of the ever smokers, about two thirds among both
males and females were former smokers, that is, they
reported that they no longer smoked.
Cessation strategies
Among former smokers, the proportion who reported
unassisted quitting was higher among females (78%)
than males (68%) (Table 3, p<0.001). Note that overall c.
6% of subjects reported using multiple aids so that per-
centages in some age groups add up to >100%. Among
the subset of ever smokers who reported having made
quit attempts with the use of a quitting aid (Table 4),
snus was the most frequently reported method among
males (63%), whereas females more frequently reported
counseling (36%), or pharmaceutical nicotine (gum 35%,
patch 22%). However, use of snus was substantially
higher among women aged below 45 years compared to
older women. In the 2009 part of the survey formerTable 1 Prevalence of current tobacco use among the subject
Males (n=2,599)
Smoking:
Snus use: Regularly Occasionally No
Regularly 1.5 2.0 14.8
Occasionally 0.8 0.5 1.6
No 7.0 3.2 68.7
Total 9.3 5.6 85.1
Females (n=3,409)
Smoking:
Snus use: Regularly Occasionally No
Regularly 0.2 0.3 1.8
Occasionally 0.4 0.2 0.9
No 10.2 3.6 82.5
Total 10.8 4.0 85.5
Results are presented as percentages of the total number of subjects for males and
population according to Statistics Sweden. P-values relate to comparisons of propo
denotes not statistically significant (p>0.05).smokers who reported that they had quit smoking by
switching to snus (n= 254) were asked to which extent
snus had helped them to quit. A total of 42% reported
that snus had helped them “to a great extent” and 35%
that snus had helped “to some extent”. These propor-
tions were similar irrespective of age and gender (data
not shown). To assess the success of the latest quit at-
tempt according to reported cessation aid, we compared
the number of ever smokers subdivided according to
quitting method at their latest quit attempt, with the
corresponding number who reported that they no longer
smoked (Table 5). Of those who had used snus, 81% of
males and 72% of females were successful quitters, com-
pared to about 50-60% for pharmaceutical nicotine and
counseling. There was no statistically significant differ-
ence according to gender in the success rate for the dif-
ferent methods. Among males, use of snus was
associated with a statistically significantly higher success
rate than the other specified methods (p<0.001). Among
females, the difference in success rate in favor of snus
was statistically significant only for the nicotine patch
comparison. Analyses with exclusion of those 6% of sub-
jects who reported using multiple aids resulted in similar
estimates and conclusions.
Discussion
The current results confirm and extend previous survey
data from Scandinavia in showing that, although most
smokers in Sweden who have quit did so unassisted,
snus continues to be the most frequently reported cessa-
tion aid among former male smokers, whereas pharma-
ceutical nicotine and counseling were more frequently
reported by females [6,7]. However, use of snus as as included in the survey
p
Total Regularly Occasionally No
18.2 <0.001 <0.001 <0.001
2.9 0.04 0.02 0.01







females separately weighted by age to correctly represent the Swedish
rtions between males and females within the same exposure category, n.s.
Table 2 Number of subjects according to age, prevalence of smoking and history/outcome of quit attempts
Age (years):
18-29 30-44 45-54 55-64 65+ Total
Males , N 262 641 433 477 774 2,599
Never smoker, % 69 65 53 37 36 53
Former smoker, % 14 20 30 47 53 32
Current smoker1, previous quit attempts, % 10 11 11 13 6 10
Current smoker1, no previous quit attempts, % 7 4 5 2 5 5
Females, N 239 783 478 637 1,232 3,409
Never smoker, % 72 61 42 40 54 56
Former smoker, % 10 27 38 40 36 30
Current smoker1, previous quit attempts, % 8 9 14 14 6 10
Current smoker1, no previous quit attempts, % 9 3 5 6 3 5
1: Subjects reporting that they smoke regularly or occasionally,0,
Data are presented as percentages of the total number of subjects according to age and gender.
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with higher usage among those aged below 45 years. Use
of snus at the latest quit attempt was associated with a
higher success rate than the other cessation aids, par-
ticularly among males, but there were no statistically sig-
nificant differences in outcome with different aids
according to gender. The main strengths of this survey
included that it was population-based and the response
rate among potentially eligible subjects was relatively
high (70.4%). The final sample size of c. 6,000 was also
quite large. The main weakness, like in many other ob-
servational studies, was that the collected information
was based on self-reports and non-smoking status wasTable 3 Smoking cessation method at the latest quit
attempt among former smokers
Age (years):
18-29 30-44 45-54 55-64 65+ Total
Males, N 34 130 131 230 409 934
Unassisted, % 54 64 62 62 75 68
Snus, % 28 28 31 28 13 22
Nicotine gum, % 5 3 4 5 4 4
Nicotine patch, % 6 0 1 3 2 2
Counseling, % 9 4 5 5 5 5
Other aid, % 8 3 2 2 3 3
Females, N 24 207 183 256 444 1,114
Unassisted, % 96 73 78 75 80 78
Snus, % 4 12 7 2 2 5
Nicotine gum, % 0 6 8 10 7 8
Nicotine patch, % 0 5 3 6 2 4
Counseling, % 0 7 8 10 8 8
Other aid, % 0 5 2 6 6 6
Note that some respondents reported using multiple aids which implies that
percentages may add up to >100%.not verified biochemically. The questionnaire was brief
and did not include more detailed questions about
tobacco habits, such as, smoking intensity, daily versus
non-daily smoking, timing and number of quit attempts,
etc. However, a more detailed questionnaire may have
resulted in a decreased response rate. The random digit
dialing (RDD) method could also be a limitation, since it
depends on the selected subject being available and will-
ing to answer the telephone call. However, each selected
subject was contacted with up to seven calls before
being replaced with a matched subject, which probably
contributed to the relatively high response rate. Another
possible limitation of the RDD method was that the se-
lection of subjects was made from a database of private
telephone lines which did not include mobile phones.
An increasing number of individuals, particularly at
younger ages, today choose to only have mobile phones
in their household which means that in the future
databases that do not include such phones may not be
representative of the Swedish population. Although
cross-sectional survey data can establish temporal rela-
tionships, such as a switch from cigarettes to snus on an
individual level, causal inferences may be difficult. How-
ever, it is noteworthy that 77% of those who successfully
switched from cigarettes to snus reported that snus had
helped them quit smoking to “a great extent” or “to
some extent”, which suggests causality.
Observations on reported quitting strategies and ces-
sation outcomes in population surveys are probably to
some extent biased by self-selection. Smokers with low
nicotine dependence may more often choose to quit un-
assisted and succeed in remaining smokefree than smo-
kers with high nicotine dependence. Among smokers
who elect to use some form of cessation aid, self-
selection between different aids is probably also a con-
cern. Some individuals may experience oral problems
Table 4 Reported smoking cessation aid used at the latest quit attempt
Age (years):
18-29 30-44 45-54 55-64 65+ Total P1 P2
Males, N 25 76 68 106 118 395
Snus, % 62 68 75 61 49 63 - <0.001
Nicotine gum, % 13 12 12 20 17 15 <0.001 <0.001
Nicotine patch, % 9 3 9 11 11 8 <0.001 <0.001
Counseling, % 20 17 21 18 22 20 <0.001 <0.001
Other, % 11 13 6 8 12 10 <0.001 <0.001
Females, N 7 76 74 97 121 377
Snus, % 71 37 23 7 10 22 -
Nicotine gum, % 15 26 43 42 36 35 0.002
Nicotine patch, % 0 23 30 27 17 22 n.s.
Counseling, % 0 30 43 41 39 36 0.001
Other, % 29 24 9 23 26 22 n.s
Data are presented as percentages of the total number of subjects according to age and gender. P1 relate to comparisons of proportions of subjects (all ages)
using snus versus other cessation methods. P2 relate to comparisons of proportions between males and females (all ages), n.s. denotes not statistically significant
(p>0.05). Note that some respondents reported using multiple aids which implies that percentages may add up to >100%.
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high pH), and some simply do not favor snus for esthetic
or other reasons. Such individuals are unlikely to try
snus for smoking cessation purposes. Self-selection
mechanisms may also be related to the long-term out-
come of quit attempts. This means that one should be
cautious with extrapolating conclusions based on survey
data about the relative efficacy of different cessation
strategies to the total population of smokers.Table 5 Outcome of latest quit attempt among subjects
who reported use of a quitting aid
Usage (%) Success rate P1 P2
Males (N=1,226):
Snus 21.6 80.7 - n.s.
Nicotine gum 5.2 58.1 <0.001 n.s.
Nicotine patch 2.9 54.9 <0.001 n.s.
Counseling 6.8 57.4 <0.001 n.s.
Other 3.5 70.5 n.s. n.s.
Females (N=1,206)
Snus 5.6 72.3 -
Nicotine gum 9.0 60.7 n.s.
Nicotine patch 5.7 48.6 0.012
Counseling 9.3 58.9 n.s.
Other 5.5 66.5 n.s.
Usage refers to proportion reporting use of a specific method to the total
number of subjects reporting a quit attempt. Success rate was defined as the
proportion of subjects reporting no smoking at the time of the survey to the
total number of subjects reporting use of the cessation aid in question. P1
relate to comparisons of the success rate for snus versus other methods. P2
relate to comparisons between males and females using the same method,
n.s. denotes not statistically significant (p>0.05).Relapse rates among smokers tend to be quite high up
to 6–12 months after a quit attempt [13]. The current
survey did not include questions about timing of the lat-
est quit attempt. This means that the calculated “success
rates” (Table 4) overestimate long term cessation out-
comes as they relate in part to quit attempts that oc-
curred only shortly before the survey. In fact, the
observed “success rates”, irrespective of cessation aid,
were considerably higher than biologically confirmed,
long-term cessation rates typically observed in con-
trolled clinical trials [3,4]. The first two randomized
trials on the role of Swedish snus to improve quit rates
among smokers were recently published [10,11]. One
was conducted in Eastern Europe (Belgrade, Serbia),
and the other at five sites in the U.S. Both were placebo-
controlled, double-blind trials testing whether ad lib
provision of snus affected subsequent smoking habits
among adult smokers. In both studies, subjects allocated
to snus were 2–3 times as likely to quit smoking com-
pletely compared to the control subjects. The trial
results support that the switch from cigarettes to snus
observed in population survey data is not only a tem-
poral phenomenon but represents a true, causal associ-
ation. The use of snus instead of cigarettes has been
suggested to simply represent a cultural phenomenon
that is particular to Scandinavia, and that snus may not
perform similarly in other countries, among females, or
in settings where pharmaceutical cessation aids are read-
ily available to smokers who want to quit [14]. The
results of the current survey as well as the mentioned
randomized trials do not support these concerns: there
was no evidence from the trials or in the survey that
snus had a differential effect according to gender, there
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Serbia, and there was no evidence (mainly based on the
U.S. trial results) that previous exposure to pharmaceut-
ical nicotine modified the effect of snus.Appendix
Questions (response alternatives within parentheses)
during the structured telephone interview (translated
from Swedish).
1. Do you smoke? (Yes, regularly/ Yes, sometimes/No,
never)
2. If you smoke, have you ever tried to quit but failed?
(Yes/No)
3. If you don’t smoke: have you smoked in the past?
(Yes/No)
4. Do you use snus? (Yes, regularly/ Yes, sometimes/
No, never)
5. If you don’t use snus, have you used snus in the
past? (Yes/No)
6. If you have smoked in the past, or smoke now but
have tried to quit, did you start using another
product when you stopped smoking, the question
relates to your latest quit attempt? (Yes/No)
7. If you started using another product, which one?
(snus/nicotine gum,/nicotine patch/other/don’t
know)
8. If you started using snus instead of smoking, to
what extent do you think snus helped you to quit
smoking? (To a great extent/To some extent/To
little extent/Not at all/Don’t know) (Question only
included in the 2009 part of the survey)
9. If you ever smoked and ever used snus, which
nicotine product did you start with? (Cigarettes/
Cigars/Pipe tobacco/Snus/Nicotine gum or other
pharmaceutical nicotine product/Other tobacco
product/Don’t know)
10. What is your age? (−29 years/20-44 years/45-54
years/55-64 years/65+ years/Don’t want to disclose
my age)
11. What is your occupation?
12. “That was all. Thank you for participating. My
name is NN and I called from Demoskop” (Subject’s
gender noted without asking)
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